and Volunteer Registries

Introduction

Recruitment speed and subject retention are critical success factors in Phase 1 clinical trials. Dedicated Phase 1 Units and established healthy volunteer databases play a central role in improving operational efficiency. These infrastructures not only accelerate screening and enrollment but also provide a controlled environment for safety monitoring, data consistency, and protocol adherence. This article highlights how these systems support early-phase trial success and outlines global best practices.

What Is a Phase 1 Unit?

A Phase 1 Unit is a specialized clinical facility designed exclusively for early-phase trials. These centers are equipped for 24/7 medical oversight, intensive PK sampling, telemetry monitoring, and multiple overnight stays.

Key Features

• Controlled inpatient environment for SAD/MAD studies
• Dedicated medical, nursing, and pharmacy teams
• On-site labs, ECG, and crash cart availability
• Integrated data capture systems (e.g., EDC, LIMS)

What Are Healthy Volunteer Databases?

• Centralized registries of pre-screened, consented individuals willing to participate in clinical trials
• Includes demographic data, past participation, medical history, contact preferences
• Used to rapidly match subjects with inclusion/exclusion criteria

Benefits of Phase 1 Units and Volunteer Databases

1. Faster Enrollment

• Units can enroll cohorts within days due to pre-screened subject pools
• Minimizes delays in dose escalation timelines

2. Reduced Screen Failures

• Subjects with prior participation history reduce protocol violations
• Centralized chart review ensures eligibility accuracy

3. Improved Subject Retention

• Comfortable accommodations and honorarium encourage completion
• Automated reminders and retention programs support compliance

4. High-Quality Data Collection

• Controlled timing of PK, vital signs, and safety assessments
• Reduced variability due to standardized processes

Volunteer Database Structure and Management

• Unique subject IDs to prevent duplicate enrollment across sites
• Documented washout periods to avoid overlap between trials
• Secure data protection and GDPR/HIPAA compliance
• Searchable filters for age, BMI, blood type, smoking status, etc.

Case Example: First-in-Human Study in India

A sponsor needed to enroll 60 healthy male subjects across 5 cohorts within 6 weeks. A CRO with its own Phase 1 Unit and a volunteer pool of 20,000+ was able to:

• Pre-screen 200 subjects using EDC-linked lab data
• Enroll each cohort within 3 days of prior cohort clearance
• Complete the study 2 months ahead of schedule

Global Models of Phase 1 Infrastructure

US & EU

• Standalone commercial Phase 1 units (e.g., Parexel, Covance, ICON)
• Embedded academic units (e.g., UCL, UCSF, CHU Clermont-Ferrand)

Japan

• Hospital-based early-phase centers with ethnic sensitivity oversight
• Limited use of healthy volunteers for CNS and oncology studies

India

• Rapidly growing FIH capacity with full-time inpatient centers
• CROs maintain national volunteer registries (e.g., >100,000 subjects)

Best Practices

• Establish long-term agreements with experienced Phase 1 Units
• Invest in centralized, privacy-compliant volunteer databases
• Use automated recruitment and screening workflows
• Conduct mock drills for cohort scheduling and dosing day logistics
• Track past participation history to avoid regulatory noncompliance